Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Chemcel Biotech IPO and Excel Infoways IPO.
Chemcel Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE while Excel Infoways IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Chemcel Biotech IPO | Excel Infoways IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | BSE | BSE, NSE |
| Lead Managers | Allahabad Bank | Chartered Capital And Investment Limited |
| Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Chemcel Biotech IPO is up to ₹24.64 Cr whereas the issue size of the Excel Infoways IPO is up to ₹48.17 Cr. The final issue price of Chemcel Biotech IPO is ₹16.00 per share and of Excel Infoways IPO is ₹85.00 per share.
| Chemcel Biotech IPO | Excel Infoways IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹85.00 per share | |
| Issue Price (Final) | ₹16.00 per share | ₹85.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 80 shares | |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 1,54,00,000 shares | 56,67,000 shares |
| Issue Size Total (Amount) | up to ₹24.64 Cr | up to ₹48.17 Cr |
Chemcel Biotech IPO opens on Sep 09, 2008, while Excel Infoways IPO opens on Jul 14, 2009. The closing date of Chemcel Biotech IPO and Excel Infoways IPO is Sep 12, 2008, and Jul 17, 2009, respectively.
| Chemcel Biotech IPO | Excel Infoways IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 09, 2008 | Jul 14, 2009 |
| Issue Close | Sep 12, 2008 | Jul 17, 2009 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Chemcel Biotech IPO P/E ratio is , as compared to Excel Infoways IPO P/E ratio of .
| Chemcel Biotech IPO | Excel Infoways IPO | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 57.23% | 96.3% | ||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 29.4% | 70.52% | ||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||
| RoNW | 9.14%% | 27.99%% | ||||||||||||||||||||||||
In the Chemcel Biotech IPO retail investors (RII) are offered while in Excel Infoways IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Chemcel Biotech IPO and 28,33,500 shares in Excel Infoways IPO.
| Chemcel Biotech IPO | Excel Infoways IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 28,33,500 shares | |
| NII | 8,50,050 shares | |
| RII | 19,83,450 shares | |
| Employee | ||
| Others | ||
| Total | 56,67,000 shares |
Chemcel Biotech IPO subscribed in total, whereas Excel Infoways IPO subscribed 1.97x.
| Chemcel Biotech IPO | Excel Infoways IPO | |
|---|---|---|
| QIB (times) | 0.49x | |
| NII (times) | 5.31x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.64x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.97x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
